Publication A prospective case control study of resistance to rifampicin, dapsone and ofloxacin in Type 1 and Type 2 leprosy reactions and the therapeutic impact of modified treatment regimen on reactions. Muddebihal A, Sardana K, Khurana A, et al. Journal of the European Academy of Dermatology and Venereology : JEADV. 2022;
Publication Leprosy chemoprophylaxis of household contacts: A survey of Canadian infectious disease and tropical medicine specialists. Boodman C, Keystone J, Bogoch I. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada. 2022; 7 (1) : 8-13. Download PDF
Publication Novel approaches in the treatment of Hansen’s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States Franco-Paredes C, Garcia-Creighton E, Henao-Martínez A, et al. SAGE Publications. Therapeutic Advances in Infectious Disease. 2022; Download PDF
Publication Drug Resistance (Dapsone, Rifampicin, Ofloxacin) and Resistance-Related Gene Mutation Features in Leprosy Patients: A Systematic Review and Meta-Analysis. Li X, Li G, Yang J, et al. International journal of molecular sciences. 2022; Download PDF
Publication Global prevalence of resistance to rifampicin in Mycobacterium leprae: A meta-analysis Wang C, Wu Z, Jiang H, et al. Elsevier BV. Journal of Global Antimicrobial Resistance. 2022; Download PDF
Publication Factsheet on SDR-PEP: The latest research on single-dose rifampicin post-exposure prophylaxis Global Partnership for Zero Leprosy , Infolep . 2022; Download PDF
Publication Ofloxacin resistance in multibacillary new leprosy cases from Purulia, West Bengal: A threat to effective secondary line treatment for rifampicin resistant leprosy cases. Ahuja M, Singh I, Lavania M, et al. Journal of global antimicrobial resistance. 2022; Download PDF
Publication Safer and newer antimicrobial drugs for leprosy – time to test monthly ROM in an adequately powered randomised trial? Lockwood DNJ, Penna GO, Lambert S, et al. Lepra. Leprosy Review. 2022; 93 (2) : 96-101. Download PDF
Publication Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan. Andrade E, Brandão J, da Silva J, et al. Antimicrobial agents and chemotherapy. 2022;
Publication Single-lesion paucibacillary leprosy: a retrospective study of 75 cases treated with the ROM scheme. Pennini SN, França J, Rebello P, et al. Anais brasileiros de dermatologia. 2022; Download PDF
Publication Acute pancreatitis associated with multibacillary polychemotherapy for leprosy. Maciel L, França L, de Deus B, et al. Revista do Instituto de Medicina Tropical de Sao Paulo. 2021; Download PDF
Publication A 5-year evaluation of chemoprophylactic treatment in elementary school children with subclinical leprosy. Astari L, Sari N, Nanang K, et al. Biomedical reports. 2021; 15 (5) : 88. Download PDF
Publication Interaction of constituents of MDT regimen for leprosy with Mycobacterium leprae HSP18: Impact on its structure and function. Chakraborty A, Ghosh R, Biswas A. The FEBS journal. 2021;
Publication The Role of Lipid and the Benefit of Statin in Augmenting Rifampicin Effectivity for a Better Leprosy Treatment Habiburrahman M, Ariq H, Yusharyahya SN. Scientific Foundation SPIROSKI. Open Access Macedonian Journal of Medical Sciences. 2021; 9 (F) : 246-259. Download PDF
Publication The nitrosamine contamination of drugs, part 3: Quantification of 4-Methyl-1-nitrosopiperazine in rifampicin capsules by LC-MS/HRMS. Wohlfart J, Scherf-Clavel O, Kinzig M, et al. Journal of pharmaceutical and biomedical analysis. 2021;
Publication Leprosy postexposure prophylaxis with single-dose rifampicin: Nepalese dermatologist's dilemma. Parajuli N, Poudyal Y. PLoS neglected tropical diseases. 2021; 15 (4) : e0009039. Download PDF
Publication Leprosy post-exposure prophylaxis risks not adequately assessed – Author's reply Richardus JH, Mieras L, Saunderson P, et al. Elsevier BV. The Lancet Global Health. 2021; 9 (4) : e402-e403. Download PDF
Publication Adverse effects of polychemotherapy for leprosy in 13 years of follow-up at a university hospital. Tortelly V, Daxbacher EL, Brotas AM, et al. Anais brasileiros de dermatologia. 2021; Download PDF
Publication Number of people requiring post-exposure prophylaxis to end leprosy: A modeling study. Taal A, Blok D, van Brakel WH, et al. PLoS neglected tropical diseases. 2021; 15 (2) : e0009146. Download PDF
Publication Análise da ocorrência de reações adversas à poliquimioterapia no tratamento para hanseníase Pires CAA, Dos Santos MAL, Biasi BH, et al. Revista Eletronica Acervo Saude. Revista Eletrônica Acervo Saúde. 2021; 13 (2) : e6233. Download PDF
